Serial 98717384
Live / Allowed — Second extension granted (statement of use) (as of 11 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Aug 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98717384
- Mark type
- Design / logo
- Filed
- 26 Aug 2024
- Published for opposition
- 17 Jun 2025
- Attorney of record
- Malaika D. Tyson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer and autoimmune disorders; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and for use in the fields of oncology and immunology
- Class 042 — Scientific and technological services: Pharmaceutical research and development; scientific research and development; medical research and development in the fields of oncology, autoimmunity, and immunology; medical research and development services in the fields of drug discovery and oncology, autoimmunity, and immunology
Owner
- Cullinan Therapeutics, Inc., Cambridge, MA, US
- Cullinan Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 12 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2026 — SOU EXTENSION 2 GRANTED
- 11 Aug 2026 — SOU EXTENSION 2 FILED
- 11 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2025 — SOU EXTENSION 1 GRANTED
- 11 Dec 2025 — SOU EXTENSION 1 FILED
- 11 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED